A team of researchers has presented an elastic implant manufactured using 3D printing capable of continuously reducing blood pressure. This biocompatible device adapts to body movements and releases medication in a controlled manner, eliminating the dose peaks typical of oral medication. The breakthrough, detailed in preclinical trials, promises to transform the treatment of hypertension, a disease affecting millions and a key factor in cardiovascular risk.
Technical design and biocompatible materials in additive manufacturing 🧬
The key to the development lies in the three-dimensional structure of the implant, created with flexible and biocompatible materials that mimic the elasticity of human tissues. 3D printing allows customizing the device's geometry to fit the patient's anatomy, ensuring secure fixation without causing rejection. Internally, the design incorporates microchannels that store the antihypertensive drug and release it sustainably through controlled diffusion. Preclinical trials demonstrated a stable reduction in blood pressure for weeks, without significant side effects, surpassing the variability of daily pill intake.
Towards personalized medicine without daily pills 💊
This implant represents a qualitative leap in treatment adherence, as it eliminates the need for the patient to remember to take their medication every day. By releasing the drug directly into the bloodstream continuously, the peaks and troughs in concentration that generate adverse effects or loss of efficacy are avoided. Researchers are already working on optimizing the design for human trials, opening the door to a new era in the management of chronic diseases where 3D printing acts as a central tool for personalized medicine.
How does the 3D printed flexible implant maintain its functionality and long-term biocompatibility inside the human body without causing rejection or premature degradation?
(PS: and if the printed organ doesn't beat, you can always add a little motor... just kidding!)